This Article
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mellor, C. S.
Right arrow Articles by Jain, V. K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Mellor, C. S.
Right arrow Articles by Jain, V. K.

Canadian Medical Association Journal, Vol 127, Issue 11 1093-1096, Copyright © 1982 by Canadian Medical Association

JOURNAL ARTICLE

Diazepam withdrawal syndrome: its prolonged and changing nature

C. S. Mellor and V. K. Jain

The diazepam withdrawal syndrome was studied in 10 patients who had abused the drug for 3 to 14 years. In the previous 6 months their consumption of diazepam had ranged from 60 to 120 mg daily; none had used other drugs during this period. The withdrawal period lasted about 6 weeks. The intensity of the symptoms and signs was high initially, fell during the first 2 weeks, then rose again in the third week, before finally declining. Three groups of symptoms and signs were identified. Group A symptoms occurred throughout withdrawal and included tremor, anorexia, insomnia and myoclonus. Group B symptoms and signs were largely confined to the first 10 days and were those of a toxic psychosis. Group C symptoms reached a peak in the third and fourth weeks of withdrawal and were characterized by sense perceptions that were either heightened or lowered. The symptom groups, the presence of tremor and myoclonus, and the relief of symptoms by a test dose permit diazepam withdrawal to be distinguished from anxiety. The biphasic course of the symptoms is probably related to the pharmacokinetics of diazepam.


This article has been cited by other articles:


Home page
 Arch NeurolHome page
P. Hauser, O. Devinsky, M. De Bellis, W. H. Theodore, and R. M. Post
Benzodiazepine Withdrawal Delirium With Catatonic Features: Occurrence in Patients With Partial Seizure Disorders
Arch Neurol, June 1, 1989; 46(6): 696 - 699.
[Abstract] [PDF]

Home page
 JAMAHome page
J. H. Woods, J. L. Katz, and G. Winger
Use and Abuse of Benzodiazepines: Issues Relevant to Prescribing
JAMA, December 16, 1988; 260(23): 3476 - 3480.
[Abstract] [PDF]

Home page
 Arch Gen PsychiatryHome page
J. C. Pecknold, R. P. Swinson, K. Kuch, and C. P. Lewis
Alprazolam in Panic Disorder and Agoraphobia: Results From a Multicenter Trial: III. Discontinuation Effects
Arch Gen Psychiatry, May 1, 1988; 45(5): 429 - 436.
[Abstract] [PDF]